Kirkpatrick Lynn's Form 4 filing
Ensysce Biosciences, Inc. (ENSC) · filed May 27, 2022
- Accession no.
- 0001493152-22-015294
- Filed
- May 27, 2022, 2:05 PM ET
- Trade date
- Feb 17-May 26, 2022
- Filing delay
- 99 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $48.3K. It was filed 99 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kirkpatrick LynnCIK 0001418785 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 25, 2022 | Common Stock | PPurchaseAcquired | +70,000 | $0.4869 | +$34,083 | 354,851 | Direct | |
| May 26, 2022 | Common Stock | PPurchaseAcquired | +27,000 | $0.5265 | +$14,215.5 | 381,851 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 | Common Stock | AGrant or awardAcquired | +200,000 | – | – | 2,516,939 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.